CD4 and neoplasm: Since studies describing the role of S1PR3 in inflammation point towards a pro-inflammatory function by increasing leukocyte rolling and inducing an inflammatory dendritic cell phenotype that activates CD4+ T cells to produce IFN-γ, one might speculate that S1PR3 activation enhances anti-tumor immunity [165,166].